RE: The Queen tests positive21 Feb 2022 11:28
I hope for Budd’s sake none of the GDR employees have shares in their own company or else he would have to tip-toe around their offices hiding from disgruntled folk asking why he can’t utter one syllable to reassure investors.
The reason is simple however, he and his sales team - imo- have not yet managed to sell a single POC product or even got a distributor in place. Regardless of actual sales an agreement with a distributor would have been announced, as it was with Beckman Coulter, to let the world know GDR is about to rocket. Alas, no. No announcement on distribution, news on UK approvals still most likely months away and Covid now pretty much being regarded like the flu by our own govt.
AIHL sales to NHS and hopefully further afield, possibly globally, will definitely help the sp recover but if we’ve fallen to 10p I’m now guessing it would only re-rate to about 30p on any positive announcements.
The Covid products are, imo, now actually obsolete and will be consigned to the cupboards at the back of GDR’s labs just on the off chance another nastier variant springs up but this, mercifully, is not looking likely. I say mercifully, I mean from a human perspective. From an investor’s POV here that’s our last hope of ever seeing the sp climb back to the mass levels of 70 - 80p.
I think if there had been any real chance/need for this Covid POC product over the last year or so then someone would have swooped in to takeover GDR lock, stock and barrel. The fact that hasn’t happened suggests to me DB has no useful contacts to even register interest. He’s an absolute disaster for GDR and it’s telling he’s not remotely interested in buying any shares in his own company even when the sp has seen a 90% decline since the recent highs of £1.50. The BOD were forced to buy shares when they did the most recent fund raise but it was hardly a huge vote of confidence in their own abilities. He clearly does not possess the requisite skills or contacts to commercialise GDR and its products and as such should either fall on his sword for the woeful performance over the last two years or apologise for leading investors up the garden path with hugely optimistic statements that have without exception come to nought.
US DoD? Nope, nothing.
BC? Not a single sale.
Eastern European country interest? Nah, again nothing.
EU approvals. Received but unable to achieve a single three months later. Not even a distribution agreement in place and they’re not attempting direct sales so that confirms for me they haven’t shifted anything.
Disaster.